Turtle Creek Wealth Advisors LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,117 shares of the medical equipment provider's stock, valued at approximately $2,039,000.
A number of other large investors have also added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new position in Intuitive Surgical during the fourth quarter valued at $25,000. Chilton Capital Management LLC raised its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares during the last quarter. Parvin Asset Management LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at $26,000. Global Financial Private Client LLC increased its holdings in shares of Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares in the last quarter. Finally, Elite Financial Inc. bought a new stake in shares of Intuitive Surgical in the 1st quarter worth $26,000. Hedge funds and other institutional investors own 83.64% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts have commented on the company. Truist Financial reduced their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada reduced their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Citigroup reissued a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Piper Sandler lowered their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price objective for the company from $515.00 to $440.00 in a research report on Monday, June 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus target price of $592.86.
View Our Latest Research Report on Intuitive Surgical
Insider Buying and Selling
In other news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director directly owned 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is currently owned by company insiders.
Intuitive Surgical Stock Performance
ISRG stock traded up $0.41 during midday trading on Wednesday, reaching $512.64. 1,842,745 shares of the company traded hands, compared to its average volume of 1,684,746. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The business has a 50 day moving average of $537.18 and a 200-day moving average of $536.37. The firm has a market capitalization of $183.74 billion, a price-to-earnings ratio of 75.17, a P/E/G ratio of 5.48 and a beta of 1.64.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the business posted $1.50 earnings per share. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.